Antibody–drug conjugates or ADCs are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. Unlike chemotherapy, ADCs are intended to target and kill tumor cells while sparing healthy cells. From Wikipedia
The deal secures antibody drug supply at Syracuse Bio Campus to support Ottimo Pharma’s path to IND submission.
